+29.1%
MRNA vs LDOS
+40.3%
-11.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | LDOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +1.1% | -0.4% | +0.4% |
| 7D | -8.2% | -2.1% | -6.1% | -7.5% |
| 30D | +125.6% | -8.0% | +133.6% | +134.6% |
| 3M | +197.1% | +6.8% | +190.2% | +197.4% |
| 6M | +148.5% | -24.5% | +172.9% | +170.1% |
| YTD | +363.3% | -27.8% | +391.0% | +407.3% |
| 1Y | +462.0% | -27.4% | +489.4% | +516.1% |
| All | +29.1% | +40.3% | -11.1% | +18.3% |
Cumulative growth
Daily Returns
Daily percentage return beside LDOS.
Daily Out/Under-Performance
Portfolio return minus LDOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LDOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded LDOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling